SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001199835-20-000232
Filing Date
2020-09-10
Accepted
2020-09-10 13:47:43
Documents
6
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 GENETHERA, INC. 10-Q/A, AMENDMENT NO. 2 form-10q.htm 10-Q/A 268291
2 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBAN ex31-1.htm EX-31.1 16553
3 CERTIFICATE OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBAN ex31-2.htm EX-31.2 15782
4 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 AS A ex32-1.htm EX-32.1 4095
5 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 AS A ex32-2.htm EX-32.2 4110
6 GRAPHIC gt001_v1.jpg GRAPHIC 10303
  Complete submission text file 0001199835-20-000232.txt   324292
Mailing Address 3051 W 105TH AVENUE UNIT 350251 WESTMINSTER CO 80031
Business Address 3051 W 105TH AVENUE UNIT 350251 WESTMINSTER CO 80031 3035069367
GENETHERA INC (Filer) CIK: 0001017110 (see all company filings)

IRS No.: 650622463 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-27237 | Film No.: 201168409
SIC: 2836 Biological Products, (No Diagnostic Substances)